Cancer Investigation · 2011 · 66 citations · 22 references
OncologyChemoprevention StrategyOncogenic AgentMedicineOscc ProliferationHbd ExpressionOral BiologyPathologyCell ProliferationHbd-1 StimulationHuman Beta-defensin-1Tumor SuppressorCancer BiologyCell BiologyCancer ResearchTumor MicroenvironmentTumor BiologyOral Cancer
The objective of this study was to investigate the impact of human beta-defensins (hBDs) on oral squamous cell carcinoma (OSCC) proliferation and hBD expression in vitro. BHY-OSCC cell lines were stimulated with hBD-1, -2, and -3. Proliferation of BHY cells was ascertained and hBD-mRNA expression was evaluated by real-time PCR. Proliferation of BHY cells decreased by 25% in response to hBD-1 stimulation but increased after stimulation with hBD-2 and -3. HBD-1 stimulation enhanced hBD-3 expression, whereas HBD-2 stimulation decreased early hBD-3 expression. HBD-3 stimulation enhanced hBD-1 expression. HBDs profoundly impact on OSCC proliferation and hBD expression in vitro. Therefore, hBD-1 might function as a tumor suppressor gene in OSCCs, while hBD-2 and -3 might be protooncogenes.
22
A new mathematical model for relative quantification in real-time RT-PCR
Michael W. Pfaffl · Nucleic Acids Research · 2001 · 34.3K citations · Full text
The novel human beta‐defensin‐3 is widely expressed in oral tissues
Anton Dunsche, Yahya Açil, Henrik Dommisch et al. · European Journal Of Oral Sciences · 2002 · 182 citations
Cancer-Specific Loss of β-Defensin 1 in Renal and Prostatic Carcinomas
Carlton D. Donald, Carrie Sun, So Dug Lim et al. · Laboratory Investigation · 2003 · 113 citations · Full text